Cells are enveloped by a lipid membrane that gives them structure and provides a barrier between the cell and its environment. However, evidence has recently emerged suggesting that these membranes do ...

Using a powerful single-molecule imaging method they developed, a Broad Institute research team has unveiled a dynamic view ...

The FDA has accepted the NDA for zipalertinib to treat adult patients with locally advanced or metastatic EGFR exon 20 insertion-mutated NSCLC.

NOTE. Percentage values in the cells may not sum up to 100% because of rounding. Bold indicates P < .05. Abbreviations: Bev, bevacizumab; ECOG-PS, Eastern Cooperative Oncology Group Performance Status ...

The findings, which led to a provisional patent filing, suggest Converge Bio improved cetuximab bindings to the receptor, achieving 2x higher affinity using a single AI prompt, strengthening its ...

Metastatic colorectal cancer continues to be a challenging disease with few major advances and many small steps forward. The refractory setting after first- and second-line chemotherapy is especially ...

The FDA has accepted a new drug application (NDA) for zipalertinib for the treatment of patients with locally advanced or ...

In this first-in-human, investigator-initiated, open-label study, three participants with recurrent glioblastoma were treated with CARv3-TEAM-E T cells, which are chimeric antigen receptor (CAR) T ...